Authors’ reply to Hamilton
BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2538 (Published 24 May 2017) Cite this as: BMJ 2017;357:j2538- Akbar K Waljee, assistant professor,
- Mary A M Rogers, research associate professor,
- Brahmajee K Nallamothu, professor
- On behalf of all the authors
- University of Michigan Medical School, Ann Arbor, MI, USA
- awaljee{at}med.umich.edu
Hamilton highlights important points.12 If the concern is that the patient has an underlying condition such as asthma, the self controlled case series (SCCS) design incorporates a within person comparison. So, if the patient had asthma for five years, this is held constant and is controlled for in the analysis. However, if the patient developed asthma after having been given the corticosteroids, having concurrent asthma was not an “indication” for prescribing the drug. The SCCS design is very powerful in controlling for underlying comorbidities (and interactions among comorbidities) in a patient. In addition, the pattern of adverse events persisted across the various indications for treatment, showing consistency regardless of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.